Back
ESC2025 Premium Access

Efficacy and safety of SGLT2 inhibitors in heart failure: real-world evidence in geriatric patients

Session: Pharmacotherapy in chronic heart failure
Topic: Pharmacotherapy
Speaker: Professor O. Hanon (Paris, FR)
Event: ESC Congress 2025

Congress Presentation

Add to my library

Like

About the speaker

Professor Olivier Hanon

Hospital Broca of Paris, Paris (France)
3 presentations
0 follower

3 more presentations in this session

Acetazolamide as an adjunct to loop diuretics in decongesting patients with acute decompensated heart failure: a systematic review and meta-analysis

Speaker: Doctor J. Interior (Quezon, PH)

Access
Abstract
Slides
Video
Like
Thumbnail

Pharmacological treatments in adults with chronic heart failure: a systematic review and component network meta-analysis

Speaker: Miss X. Zou (Chengdu, CN)

Access
Abstract
Slides
Video
Like
Thumbnail

Synthetic HRV assessment of autonomic modulation effects induced by empaglifozin added to optimized therapy in a patient with post-COVID paroxysmal atrial fibrillation-induced heart failure and normal

Speaker: Assistant Professor D. Brisinda (Rome, IT)

Access
Abstract
Slides
Video
Like
Thumbnail

Access the full session

Pharmacotherapy in chronic heart failure

Speakers: Professor O. Hanon, Doctor J. Interior, Miss X. Zou, Assistant Professor D. Brisinda
Access
Like
Thumbnail

About the event

Image

ESC Congress 2025

29 August - 1 September 2025

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

bristol-myers-squibb Explore sponsored resources
novartis Explore sponsored resources
novo-nordisk Explore sponsored resources